Intended for healthcare professionals

Letters Adverse effects of statins

Retraction of statins article is not in the public interest: better characterisation of benefits and risks is crucial

BMJ 2014; 348 doi: (Published 18 June 2014) Cite this as: BMJ 2014;348:g4028
  1. Tom Fahey, professor of general practice1,
  2. Susan Smith, associate professor of general practice1
  1. 1Royal College of Surgeons in Ireland Medical School, Dublin 2, Republic of Ireland
  1. tomfahey{at}

Abramson and colleagues highlight uncertainties about adverse effects of statins for the primary prevention of cardiovascular disease in patients at low absolute cardiovascular risk.1 2 There is a substantial discrepancy between observational studies and randomised controlled trials (RCTs) regarding the reporting of adverse effects of statins. This could be the result of under-reporting of “mild” adverse effects in RCTs …

View Full Text

Log in

Log in through your institution


* For online subscription